The Analyst

CORNERSTONE RESEARCH Cornerstone Research is a consulting firm specializing in the analysis of complex financial, economic, accounting, and marketing issues. In recent years, Cornerstone Research has become one of the nation’s leading finance and economics consulting firms with more than 700 full-time staff members across eight offices. We attribute our success to a unique combination of resources: a creative and energetic staff, cutting-edge research, and our network of academic and industry experts. Our consultants employ innovative problem solving approaches and achieve unparalleled analytic depth. Cornerstone Research has consulted on a wide variety of projects involving numerous industries. Our clients include major securities firms, top consulting and other professional service firms, leading pharmaceutical companies, major participants in energy markets, over one hundred Internet and other high-technology firms, and large telecommunications providers. These companies often have a large percentage of their net worth at stake when they seek our services. As such, our projects receive focused attention from chief executive officers and boards of directors of our clients. Our diverse experience allows us to provide clients with a unique breadth of perspective and expertise. For example, in securities projects we analyze stock prices, derivatives and debt instruments. We assess high-profile mergers and acquisitions, insider trading allegations and share repurchase transactions. In antitrust and intellectual property cases we look at industry structure, the nature of purchase decisions, and the commercial value of innovation and technology. The types of projects that Cornerstone Research works on, along with sample headlines, include: Securities: Jury Rejects $20 Billion Claim in JDSU Trial Antitrust: Federal Court Dismisses Suit Seeking to Block InBev’s Acquisition of Anheuser-Busch Energy: Court Rejects Plaintiffs’ Claim of Predatory Injury from Below-Cost Sales Intellectual Property: Jury Awards Siemens Medical $52 Million in Patent Dispute Accounting: Shareholder Lawsuit Dismissed for Lack of Loss Causation